Consensus Alcon Inc. Swiss Exchange

Stocks

ALCE

CH1557600348

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 01:30:14 06/08/26 am AEST			5-day change	1st Jan Change
57.12 ^CHF	-0.66%		-.--%	-

02/10	AlphaValue/Baader Europe Upgrades Alcon to Buy	MT
29/09	Alcon Inc. Launches Systane PRO PRESERVATIVE-FREE in Canada	CI

45bcab525.iN_S_n8AgNzDHmHVP6qTk9Wk0AFkA3QSqFVdX4SthlQ.5-iamwxOsJeFWwmmB9rf2ef1tDQQRUdb62ILMdXDvjLem7OYTzbXtblLVQ~46e6c9bb1ad74dfd8e45bfdf79abbcb0

Analysts' recommendations: Alcon Inc.

02/10	AlphaValue/Baader Europe Upgrades Alcon to Buy	MT
24/09	Bernstein: Alcon a 'Top Long-term Compounder' Amid 'Transitory' Near-term Pressures	MT
11/09	Berenberg Sees Alcon as 'Best Way' into Ophthalmology Market Exposure; Buy Rating Affirmed	MT
17/08	Deutsche Bank raises TP for Alcon, but shares down
13/08	BNP Paribas Downgrades Alcon to Neutral, Cuts PT	MT
13/08	Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2	MT
12/08	Alcon: Q2 story: Innovation is being well received by the end market
25/05	Baptista Research Upgrades Alcon to Buy Rating	MT
13/05	Swiss Market Index Closes Higher; SoftwareOne Shares Jump	MT
08/05	Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised	MT
07/05	Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating	MT
07/05	Alcon: Results weren't bad; today's correction is a buying opportunity
06/05	Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses	MT
06/05	Swiss stocks - Factors to watch on May 6	RE
06/05	Alcon: Investment case hinges on profitability expansion
21/04	RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained	MT
20/03	AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT	MT
16/03	Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In	MT
10/03	Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26	MT
06/03	Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound	MT
04/03	Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised	MT
27/02	Equita SIM Upgrades Alcon to Buy, Raises PT	MT
27/02	Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating	MT
27/02	Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88	MT
26/02	Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up	MT

More recommendations

Glasses, Spectacles & Contact Lenses

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+23.68%
	MEDTRONIC PLC					+21.36%
	STRYKER CORPORATION					+33.54%
	ESSILORLUXOTTICA					+62.89%
	CENCORA, INC.					+19.48%
	HOYA CORPORATION					+24.9%
	BECTON, DICKINSON AND COMPANY					+10.67%
	IDEXX LABORATORIES, INC.					+35.29%
	DEXCOM, INC.					+11.39%
	Average					+27.02%
	Weighted average by Cap.					+27.95%